Longevity, Skin & Wellness

GHK-Cu

A copper peptide positioned for skin quality, scalp health, and tissue-support goals.

Download evidence brief

Injectable

1.5% cream

Common goals: Potential improvements in the appearance of fine lines, firmness, texture, and overall skin quality.
Best program fit: May fit aesthetic, scalp, post-procedure, or skin-quality programs with photography-based follow-up.
Format: Injectable · 1.5% cream

Partner education guide

Where this may fit in an offering.

Potential improvements in the appearance of fine lines, firmness, texture, and overall skin quality. A repair-oriented treatment story that may appeal to individuals focused on skin renewal, scalp health, or post-procedure support. Topical formats can fit naturally into aesthetic, skin-quality, and healthy-aging programs.

Educational business-planning summary. Potential benefits vary, are not guaranteed, and require individual-specific clinical review.

01 / Common goals

What people may want to understand.

Primary goals

Potential benefits and goals

Potential improvements in the appearance of fine lines, firmness, texture, and overall skin quality.
A repair-oriented treatment story that may appeal to individuals focused on skin renewal, scalp health, or post-procedure support.
Copper-peptide biology provides a plausible pathway for collagen signaling, tissue remodeling, and antioxidant support.

Program value

How it may support a program

Topical formats can fit naturally into aesthetic, skin-quality, and healthy-aging programs.
May pair well with photography-based tracking and a broader clinician-directed skin-care plan.

Potential benefits are informed by small cosmetic studies and preclinical research and are not guaranteed. Results depend on formulation, route, concentration, and individual selection.

02 / Program fit

Program and operational considerations.

01Administration: Catalog format: Injectable · 1.5% cream. The prescribing clinician and dispensing pharmacy confirm the exact preparation, concentration, handling, and administration technique.
02Typical frequency: Frequency is individualized around the exact formulation, individual goals, tolerability, and monitoring plan.
03Expected duration: If a topical trial is chosen, visible skin change would generally be assessed over at least 8 to 12 weeks. Long-term injected treatment has not been adequately studied.
04Practical advantages: Topical formats can fit naturally into aesthetic, skin-quality, and healthy-aging programs.

03 / Suitability considerations

Who may be considered.

Who may be considered

A carefully screened adult whose goals align with the potential benefits above and who understands that individual response varies.
An individual willing to complete clinician-directed baseline review, monitoring, and an outcome-based follow-up plan.

Qualification notes

Topical formats can fit naturally into aesthetic, skin-quality, and healthy-aging programs.
Strongest fit occurs when the exact formulation, route, source, contraindications, and measurable goals can be clearly documented.

04 / Safety & suitability

What must be screened before treatment.

Common or temporary

Topical use may cause redness, stinging, dryness, rash, or contact irritation.
Injection may cause pain, bruising, swelling, discoloration, or a local reaction. Reliable frequencies are not available.

Serious or important

Injection adds risks from contamination, infection, dosing error, hypersensitivity, and uncharacterized systemic copper exposure.
Long-term injected safety, reproductive safety, drug interactions, and effects in cancer or copper-metabolism disorders are not established.

Avoid or use only with specialist input

Use on infected, severely inflamed, ulcerated, or undiagnosed skin without medical assessment.
Routine injection during pregnancy or breastfeeding, in a copper-metabolism disorder, or when product identity and sterility cannot be verified.

Screening checklist

Clarify the goal, route, complete ingredient list, allergy history, active dermatologic conditions, pregnancy status, and concurrent retinoids or irritating products.
For topical use, consider a small-area patch test and standardized baseline photographs. For injection, require medical review of product source, copper exposure, and the absence of a validated regimen.

When to refer

Refer changing lesions, unexplained hair loss, chronic wounds, infection, severe dermatitis, or a systemic reaction to an appropriately qualified clinician.

Safety information is not exhaustive. Prescribing, screening, dosing, monitoring, and emergency guidance must come from an appropriately licensed clinician and the exact product information.

What the research says · reviewed August 2026

Research and source context.

Human topical data are weak and injection data are absent.

01 / Human research

The clearest clinical signal

Human skin claims rest mostly on small, older, poorly reported cosmetic studies and mixed-ingredient products. A 2025 review found a surprising lack of strong GHK-Cu clinical trials.

02 / Real-world reports

What people describe

About eight topical and six injection accounts were sampled. Topical users often reported subtle skin texture change after 4-12 weeks; many saw no clear change. Injection users described stinging, blue-green residue, nausea, or no effect.

Public personal accounts are unverified and cannot show how common an outcome is.

03 / Cautions

What deserves attention

Cream may cause irritation or allergy. Injection adds infection, contamination, dosing, and copper-exposure risks. Long-term injected safety is unknown.

Does the research match this exact product?

Cell studies and cosmetic mixtures do not directly validate this 1.5% cream or injection.

Complete evidence briefClinical summary, safety notes, reported timing, regulatory context, and linked sources in one document.

Download the evidence briefPDF · larger type

Evidence and regulatory status can change. Confirm the current label, formulation, route, dose, pharmacy source, jurisdiction, and intended use before offering treatment.

Education before offering.

Treatment information is for education only. It is not medical advice. A licensed clinician will review your health and decide whether a treatment is appropriate for you. Eligibility and availability may vary.

Back to all treatments